市場調査レポート

商品コード

1540809

バイオセンサー市場レポート：製品、技術、用途、最終用途、地域別、2024～2032年

Biosensors Market Report by Product, Technology, Application, End Use, and Region 2024-2032

出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 440,313円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,999 587,133円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 733,953円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のバイオセンサー市場規模は2023年に288億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに554億米ドルに達し、2024～2032年の間に7.3％の成長率（CAGR）を示すと予測しています。技術の進歩、慢性疾患の有病率の上昇、POCT（ポイントオブケア試験）需要の増加、医療、食品、環境モニタリングにおけるアプリケーションの拡大、政府の取り組み、研究開発（R&D）への投資、ウェアラブルバイオセンサの出現、精密医療と個別化治療アプローチへの注目の高まりなどは、市場成長を後押しする要因の一部です。

バイオセンサー市場分析：

主要市場促進要因：急速に拡大する世界のバイオセンサー市場は、糖尿病や心血管疾患のような慢性疾患の罹患率の上昇により、継続的に動作するバイオセンサーの必要性が主要要因となっています。さらに、精度と信頼性の向上に対するニーズの高まりは、関連するバイオセンサー技術の技術進歩を加速させ、ナノ技術やマイクロ流体工学の発展につながり、バイオセンサー市場のシェアをさらに押し上げています。もう1つの重要な要因は、医療目的やポイントオブケア試験（POCT）のためのウェアラブルの普及が進んでいることです。さらに、個別化医療が受け入れられ、患者データをリアルタイムで取得する需要が高まるにつれて、バイオセンサーの需要も増加しており、これが市場の成長を刺激しています。これとは別に、高度なバイオセンサー技術の開発に対する政府の様々な取り組みや資金提供、環境のモニタリングや食品の安全性の試験におけるバイオセンサーの用途の拡大が、市場の成長を支えています。

主要市場動向：市場を形成する主要なバイオセンサー市場動向には、バイオセンサーを人工知能（AI）や機械学習（ML）と統合し、より分析的で予測的な診断ができるようにすることが含まれます。グルコースモニタリング用の非侵襲性バイオセンサーの開発や、他のセグメントへの応用に向けた取り組みが活発化していることが、市場の成長を後押ししています。さらに、バイオセンサーは現場、現場、生体内で使用できるように小型化されており、これも成長を促す要因となっています。スマートウォッチやフィットネストラッカーのような製品に内蔵されたセンサーにより、ウェアラブル健康モニタリングデバイスの使用は増加傾向にあり、これによりユーザーはさまざまな身体データを測定できるようになり、これがバイオセンサー市場の成長を加速しています。もう1つの主要動向は、スマート農業における土壌や作物の健康モニタリング用のバイオセンサーの出現です。

地理的動向：米国は、強固な医療インフラの存在、最先端の医療技術の利用、研究開発（R&D）への多額の投資により、北米地域のバイオセンサー市場を支配しています。さらに、この地域にはバイオセンサー市場をリードする企業が複数あり、医療イノベーションを支援する中央政府のイニシアチブもあります。欧州は、医療費の増加と技術の進歩により、そのバイオセンサー市場で劇的な発展を遂げ、後塵を拝しています。アジア太平洋は、慢性疾患の増加、医療意識の向上、医療インフラの成長により、最も急速に成長する市場と予測され、同地域のバイオセンサー需要をさらに牽引しています。

競合情勢：市場の競合情勢は、Abbott Laboratories、AgaMatrix Inc.（WaveForm Technologies Inc）、DuPont de Nemours Inc.、F. Hoffmann-La Roche AG、General Electric Company、LifeScan Inc.（Platinum Equity LLC）、Medtronic PLC、Nova Biomedical Corporation、PHC Holdings Corporation、Siemens AG、Thermo Fisher Scientific Inc.などの企業の存在によって特徴付けられます。

課題と機会：例えば、高い開発・製造コストがバイオセンサー技術へのアクセスや入手の可能性を制限しています。規制のハードルや厳しい承認プロセスは、市場参入や商業化の課題となっています。さらに、特に複雑な診断用途では、バイオセンサーの精度と信頼性に関する問題に対処する必要があります。しかし、これらの課題は技術革新と改善の機会でもあります。個別化医療への注目の高まりとポイントオブケア診断への需要の高まりは、バイオセンサーメーカーに大きな成長機会を提供し、これがバイオセンサー市場展望に拍車をかけています。

バイオセンサー市場動向：

技術の進歩

バイオセンサーの技術的進歩は、センサー設計、材料、製造における絶え間ない技術革新により、極めて高感度、高精度、コスト効率の高いセンサーとして発展してきました。バイオセンサーは、新しい材料、ナノ技術、マイクロ流体工学を取り入れることで、その性能と機能性が大幅に改善され、その結果、優れた感度と選択性で幅広い分析対象物を検出できるようになりました。これに加えて、バイオセンサーの小型化と電子機器との統合により、医療診断、環境モニタリング、食品安全など、多くの用途セグメントに適したものとなっています。これらの開発により、バイオセンサーシステムの性能と信頼性が向上し、製造コストが低下するため、より多くの消費者市場で使用されるようになります。

慢性疾患の増加

世界中で慢性疾患の罹患率が増加していることも、バイオセンサーのニーズを後押しする重要な役割を果たしています。業界レポートによると、米国では総コレステロール値が高い（240mg/dL以上）成人の数は2,470万人と推定されています。糖尿病、心血管疾患（CVDs）、がんなどの慢性疾患は、世界中の医療システムに負担をかけており、早期発見とモニタリングのための新しい診断方法の開発が求められています。バイオセンサーの最も有利な用途の一つは、疾患に関連する生物学的分析物（バイオマーカー）を迅速、高感度、非侵襲的に検出することであり、これによりタイムリーな介入と個別化治療の選択肢が可能になります。さらに、世界の人口の高齢化、座りがちなライフスタイル、食事パターンの大幅な変化によって、慢性疾患の世界の負担がさらに増加するにつれて、バイオセンサーの需要は増加し、それによって市場の成長が促進される可能性が高いです。

ポイントオブケア試験の需要拡大

ポイントオブケア試験需要の増加は、特に分散型医療や資源が限られた環境におけるバイオセンサの成長を促進します。ポイントオブケア試験は、迅速な診断と治療の決定を可能にするため、迅速な結果、所要時間の短縮、患者の転帰の改善など、多くの利点があります。ポータブル型ポイントオブケア試験機器は、クリニック、病院、在宅医療の現場で使用されるようになってきており、リアルタイムの出力結果に基づいています。さらに、予防医療と早期疾病診断への注目の高まりは、POCTを医療実践の鍵と見なし、医療ワークフローにバイオセンサを組み込む需要をさらに高めています。

北米
- 米国
- カナダ
アジア太平洋
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測

第11章 SWOT分析

概要
強み
弱み
機会
脅威

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第14章価格分析

第15章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Abbott Laboratories
- AgaMatrix Inc.（WaveForm Technologies Inc）
- DuPont de Nemours Inc.
- F. Hoffmann-La Roche AG
- General Electric Company
- LifeScan Inc.（Platinum Equity LLC）
- Medtronic PLC
- Nova Biomedical Corporation
- PHC Holdings Corporation
- Siemens AG
- Thermo Fisher Scientific Inc.

図表

List of Figures

Figure 1: Global: Biosensors Market: Major Drivers and Challenges
Figure 2: Global: Biosensors Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Biosensors Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Biosensors Market: Breakup by Product (in %), 2023
Figure 5: Global: Biosensors Market: Breakup by Technology (in %), 2023
Figure 6: Global: Biosensors Market: Breakup by Application (in %), 2023
Figure 7: Global: Biosensors Market: Breakup by End Use (in %), 2023
Figure 8: Global: Biosensors Market: Breakup by Region (in %), 2023
Figure 9: Global: Biosensors (Wearable) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Biosensors (Wearable) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Biosensors (Non-Wearable) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Biosensors (Non-Wearable) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Biosensors (Electrochemical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Biosensors (Electrochemical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Biosensors (Optical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Biosensors (Optical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Biosensors (Piezoelectric) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Biosensors (Piezoelectric) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Biosensors (Thermal) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Biosensors (Thermal) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Biosensors (Nanomechanical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Biosensors (Nanomechanical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Biosensors (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Biosensors (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Biosensors (Blood Glucose Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Biosensors (Blood Glucose Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Biosensors (Cholesterol Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Biosensors (Cholesterol Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Biosensors (Blood Gas Analysis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Biosensors (Blood Gas Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Biosensors (Pregnancy Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Biosensors (Pregnancy Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Biosensors (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Biosensors (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Biosensors (Infectious Disease Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Biosensors (Infectious Disease Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Biosensors (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Biosensors (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Biosensors (Point of Care Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Biosensors (Point of Care Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: Biosensors (Home Healthcare Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: Biosensors (Home Healthcare Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: Biosensors (Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: Biosensors (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Global: Biosensors (Security and Biodefense) Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Global: Biosensors (Security and Biodefense) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Global: Biosensors (Other End uses) Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Global: Biosensors (Other End uses) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: North America: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: North America: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: United States: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: United States: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Canada: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Canada: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Asia-Pacific: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Asia-Pacific: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: China: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: China: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Japan: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Japan: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: India: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: India: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: South Korea: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: South Korea: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Australia: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Australia: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Indonesia: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Indonesia: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Others: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Others: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Europe: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Europe: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Germany: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Germany: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: France: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: France: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: United Kingdom: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: United Kingdom: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Italy: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Italy: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Spain: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Spain: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Russia: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Russia: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Others: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Others: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Latin America: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Latin America: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Brazil: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Brazil: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Mexico: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Mexico: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Others: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 94: Others: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 95: Middle East and Africa: Biosensors Market: Sales Value (in Million US$), 2018 & 2023
Figure 96: Middle East and Africa: Biosensors Market: Breakup by Country (in %), 2023
Figure 97: Middle East and Africa: Biosensors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 98: Global: Biosensors Industry: SWOT Analysis
Figure 99: Global: Biosensors Industry: Value Chain Analysis
Figure 100: Global: Biosensors Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Biosensors Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Biosensors Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Biosensors Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Biosensors Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Biosensors Market Forecast: Breakup by End Use (in Million US$), 2024-2032
Table 6: Global: Biosensors Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Biosensors Market: Competitive Structure
Table 8: Global: Biosensors Market: Key Players

Product Code: SR112024A4130

The global biosensors market size reached US$ 28.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 55.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032. Technological advancements, rising prevalence of chronic diseases, increasing demand for point-of-care testing (POCT), the expanding applications in healthcare, food, and environmental monitoring, government initiatives, investments in research and development (R&D), emergence of wearable biosensors, and the growing focus on precision medicine and personalized treatment approaches are some of the factors favoring the market growth.

Biosensors Market Analysis:

Major Market Drivers: The rapidly expanding global biosensors market is primarily bolstered by the need for bio sensors that operate on a continuous basis due to the rising incidence of chronic diseases like diabetes and cardiovascular issues. Moreover, the escalating need for improved accuracy and reliability has accelerated technological advancements in relevant biosensor technologies, which has further led to the development of nanotechnology and microfluidics, further boosting the biosensors market share. Another crucial factor is the increasing uptake of wearables for medical purposes and point-of-care testing (POCT). Furthermore, with increasing acceptance of personalized medicine and demand for real-time patient data the demand for biosensors has increased, which is stimulating the market growth. Apart from this, the various government initiatives and funding for the development of advanced biosensors technologies and the growing application of biosensors in monitoring the environment and testing for food safety are supporting the market growth.

Key Market Trends: The key biosensors market trends shaping the market includes the integration of biosensors with artificial intelligence (AI) and machine learning (ML) to make them more analytical and predictive for diagnostics. The escalating efforts to develop non-invasive biosensors for glucose monitoring, as well as applications in other fields, are favoring the market growth. Additionally, biosensors have been miniaturized for in field, on-site and in vivo use, which is another growth-inducing factor. The use of wearable health monitoring devices is on the rise due to the sensors built into products like smartwatches and fitness trackers, which allows users to measure a variety of physical data, which is accelerating the biosensors market growth. Another key trend is the emergence of biosensors for soil and crop health monitoring in smart agriculture.

Geographical Trends: The U.S. dominates the biosensors market the North American region due to the presence of a robust healthcare infrastructure, the use of cutting-edge medicinal advancements, and considerable investment in research and development (R&D). Additionally, the region boasts several biosensor market leaders, along with central government initiatives to support healthcare innovation. Europe trails close behind, a dramatic development in its biosensors market due to the rising healthcare expenditure and technology advancements. Asia-Pacific is projected to be fastest growing market, attributed to increasing prevalence of chronic diseases, improving healthcare awareness, and growing healthcare infrastructure, which is further driving the biosensors demand in the region.

Competitive Landscape: The competitive landscape of the market is characterized by the presence of companies, such as Abbott Laboratories, AgaMatrix Inc. (WaveForm Technologies Inc), DuPont de Nemours Inc., F. Hoffmann-La Roche AG, General Electric Company, LifeScan Inc. (Platinum Equity LLC), Medtronic PLC, Nova Biomedical Corporation, PHC Holdings Corporation, Siemens AG, Thermo Fisher Scientific Inc., etc.

Challenges and Opportunities: There are a variety of challenges that affect the biosensors market, such as the high development and production costs, which can limit the accessibility and affordability of biosensor technologies. Regulatory hurdles and stringent approval processes pose challenges for market entry and commercialization. Additionally, issues related to the accuracy and reliability of biosensors, particularly in complex diagnostic applications, need to be addressed. However, these challenges present opportunities for innovation and improvement. The increasing focus on personalized medicine and the growing demand for point-of-care diagnostics offer significant growth opportunities for biosensor manufacturers, which is fueling the biosensors market outlook.

Biosensors Market Trends:

Technological Advancements

Technological advancements in biosensors have been developed as extremely sensitive, accurate, and cost-efficient sensors due to the continuous innovation in the design of sensors, materials, and manufacturing. They have been significantly improved in their performance and functionalities through the incorporation of novel materials, nanotechnology, and microfluidics, which enables their application to be sensing a wide range of analytes with such superior sensitivity and selectivity. In addition to this, miniaturization and integration of biosensors with electronic devices has made them more suitable to a number of application fields such as medical diagnostics, environmental monitoring, and food safety. These developments lead to better performance and reliability of their biosensor systems, as well as lower production costs that help in democratizing the usage to a larger marketplace of consumers.

Increasing Prevalence of Chronic Diseases

The growing incidence of chronic diseases across the globe also plays an important role, driving the need for biosensors. As per our industry reports, in the US, the number of adults suffering from high total cholesterol status (>= 240 mg/dL) was estimated to be 24.7 million. Chronic conditions, such as diabetes, cardiovascular diseases (CVDs), and cancer, burden healthcare systems around the world, calling for the development of new diagnostic methods for early detection and monitoring. One of the most advantageous applications of biosensors is rapid, sensitive, and non-invasive detection of disease associated biological analytes (biomarkers) that enables for timely intervention and personalized treatment alternatives. Moreover, with a further increase in the global burden of chronic diseases, facilitated by aging global populations, sedentary lifestyles, and significant changes in dietary patterns, the demand for biosensors is likely to increase, thereby pushing the market growth.

Growing Demand for Point-of-Care Testing

The increasing point-of-care testing (POCT) demand drives the growth of biosensors, especially in the decentralized healthcare as well as resource-limited settings. Point-of-care testing has a number of benefits, such as quick results, shorter turnaround times and better patient outcomes as it allows for immediate diagnostics and treatment decisions. These are portable, point of care (POCT) devices, which are increasingly being used in clinics, hospitals, home care settings and based on real-time output-results. Moreover, the rising focus on preventive healthcare and early disease diagnosis is identifying POCT as a key in healthcare practices, which is further surging the demand for incorporating biosensors in healthcare workflows.

Biosensors Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the product, technology, application, and end use.

Breakup by Product:

Wearable Biosensors

Non-Wearable Biosensors

The report has provided a detailed breakup and analysis of the market based on the product. This includes wearable biosensors and non-wearable biosensors.

The wearable biosensors segment is driven by the increasing demand for continuous health monitoring and personalized medicine. Consumers are increasingly adopting wearable devices such as smartwatches and fitness trackers that incorporate biosensors to monitor vital signs, physical activity, and other health metrics in real-time. Advances in sensor technology, miniaturization, and wireless connectivity have enhanced the functionality and accuracy of wearable biosensors, making them more attractive to users. Additionally, the growing prevalence of chronic diseases and the aging population are fueling the need for remote patient monitoring and early detection of health issues, further boosting the adoption of wearable biosensors. The integration of biosensors with smartphones and other portable devices facilitates seamless data transmission and analysis, providing users and healthcare providers with valuable insights for managing health and wellness.

The non-wearable biosensors segment is driven by the increasing applications in medical diagnostics, environmental monitoring, and food safety. In medical diagnostics, non-wearable biosensors are widely used for detecting various biomarkers, pathogens, and diseases, offering rapid, accurate, and cost-effective solutions for clinical and laboratory settings. Environmental monitoring applications leverage non-wearable biosensors to detect pollutants, toxins, and other harmful substances in air, water, and soil, contributing to public health and safety. In the food industry, non-wearable biosensors are utilized for quality control and safety assurance by detecting contaminants and ensuring compliance with regulatory standards. The rising awareness about the importance of early disease detection, environmental protection, and food safety is driving the demand for non-wearable biosensors.

Breakup by Technology:

Electrochemical Biosensors

Optical Biosensors

Piezoelectric Biosensors

Thermal Biosensors

Nanomechanical Biosensors

Others

The report has provided a detailed breakup and analysis of the market based on the technology. This includes electrochemical biosensors, optical biosensors, piezoelectric biosensors, thermal biosensors, nanomechanical biosensors, and others.

The electrochemical biosensors segment is driven by the increasing demand for highly sensitive and selective detection methods in medical diagnostics, environmental monitoring, and food safety. The ability of electrochemical biosensors to provide rapid, accurate, and cost-effective analysis makes them highly desirable across various applications. Advances in nanotechnology and materials science have further enhanced their performance, enabling the development of miniaturized and portable devices. Additionally, the rising prevalence of chronic diseases, such as diabetes, necessitates the widespread use of electrochemical biosensors for continuous glucose monitoring, thereby fueling market growth.

The optical biosensors segment is driven by the increasing need for high-throughput and label-free detection methods in research, clinical diagnostics, and environmental monitoring. Optical biosensors offer exceptional sensitivity and specificity, making them ideal for detecting a wide range of analytes, including biomolecules, pathogens, and pollutants. Advances in photonics and biophotonics have significantly improved the performance of optical biosensors, enabling real-time and multiplexed detection. The growing adoption of point-of-care testing and personalized medicine further boosts the demand for optical biosensors, as they provide rapid and accurate results.

The piezoelectric biosensors segment is driven by the increasing utilization in applications requiring the detection of mechanical changes due to their high sensitivity and rapid response time. These biosensors are particularly effective in detecting mass changes, making them valuable in various fields, including medical diagnostics, environmental monitoring, and industrial processes. The growing demand for portable and non-invasive diagnostic tools is fueling the adoption of piezoelectric biosensors. Furthermore, advancements in piezoelectric materials and microfabrication technologies have enhanced the performance and miniaturization of these sensors, broadening their application scope.

The thermal biosensors segment is driven by the increasing need for highly accurate and reliable temperature-based detection methods in biomedical and industrial applications. Thermal biosensors, which measure changes in temperature as a result of biochemical reactions, offer high sensitivity and specificity. They are widely used in monitoring metabolic activities, detecting pathogens, and assessing food quality. The advancements in microelectromechanical systems (MEMS) and nanotechnology have significantly improved the performance of thermal biosensors, enabling their miniaturization and integration into portable devices.

The nanomechanical biosensors segment is driven by the increasing demand for ultra-sensitive detection methods capable of measuring minute changes at the nanoscale. These biosensors leverage mechanical properties such as mass, stiffness, and surface stress to detect the presence of analytes with high precision. The growing applications in genomics, proteomics, and environmental monitoring are boosting the adoption of nanomechanical biosensors. Advances in nanotechnology and materials science have enabled the development of highly sensitive and miniaturized nanomechanical biosensors, expanding their utility in various fields.

The others segment, which includes emerging biosensor technologies such as magnetic, acoustic, and thermal biosensors, is driven by the increasing need for innovative and versatile detection methods across various industries. These biosensors offer unique advantages, including high sensitivity, specificity, and the ability to detect a wide range of analytes. The growing demand for advanced diagnostic tools, environmental monitoring systems, and food safety solutions is fueling the development and adoption of these biosensors.

Breakup by Application:

Blood Glucose Testing

Cholesterol Testing

Blood Gas Analysis

Pregnancy Testing

Drug Discovery

Infectious Disease Testing

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes blood glucose testing, cholesterol testing, blood gas analysis, pregnancy testing, drug discovery, infectious disease testing, and others.

The glucose testing segment is driven by the increasing prevalence of diabetes worldwide, which necessitates continuous monitoring and management of blood glucose levels. Advances in biosensor technology have led to the development of more accurate, user-friendly, and cost-effective glucose monitoring devices, including continuous glucose monitors (CGMs) and self-monitoring blood glucose (SMBG) systems. These innovations have significantly improved patient compliance and outcomes by enabling real-time glucose tracking and data integration with digital health platforms.

The cholesterol testing segment is driven by the increasing incidence of cardiovascular diseases (CVDs), which are closely linked to high cholesterol levels. Early detection and management of cholesterol are crucial for preventing CVDs, leading to a higher demand for cholesterol testing biosensors. Technological advancements have resulted in more reliable and faster cholesterol testing devices, including portable and point-of-care systems that provide immediate results. Additionally, rising health consciousness, routine health check-ups, and the emphasis on preventive healthcare practices have spurred the adoption of cholesterol testing biosensors.

The blood gas analysis segment is driven by the increasing prevalence of respiratory and metabolic disorders that require precise monitoring of blood gas levels. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, and renal diseases necessitate regular blood gas analysis to manage and adjust treatment plans effectively. Technological advancements have led to the development of portable and point-of-care blood gas analyzers, making it easier for healthcare providers to perform timely and accurate assessments. Furthermore, the growing adoption of these devices in emergency and critical care settings, where rapid decision-making is crucial, significantly contributes to the market's expansion.

The pregnancy testing segment is driven by the increasing demand for home-based and point-of-care diagnostic solutions that offer convenience and privacy. Technological advancements have led to the development of highly sensitive and easy-to-use pregnancy test kits that provide quick and accurate results. The rising awareness about reproductive health and the importance of early pregnancy detection for better prenatal care have also fueled the demand for these testing kits. Additionally, the increasing prevalence of planned pregnancies, coupled with the availability of affordable and accessible testing solutions, further boosts the market.

The drug discovery segment is driven by the increasing need for efficient and cost-effective methods to identify new therapeutic compounds and evaluate their efficacy and safety. Biosensors offer significant advantages in drug discovery by enabling real-time, high-throughput screening of potential drug candidates. Technological advancements have enhanced the sensitivity and specificity of biosensors, making them invaluable tools in the early stages of drug development. Additionally, the growing prevalence of chronic diseases and the demand for personalized medicine have spurred investment in biosensor technologies to accelerate drug discovery processes.

The infectious disease testing segment is driven by the increasing incidence of infectious diseases globally, necessitating rapid and accurate diagnostic solutions. Biosensors offer significant advantages in the early detection and monitoring of infectious agents, enabling timely intervention and containment. Technological advancements have led to the development of highly sensitive and portable biosensors that can detect a wide range of pathogens, including viruses, bacteria, and fungi. The ongoing threat of pandemics and emerging infectious diseases has further highlighted the importance of efficient diagnostic tools, driving investment and innovation in this segment.

The others segment, encompassing various applications such as environmental monitoring, food safety, and bioprocessing, is driven by the increasing need for real-time, accurate, and cost-effective analytical solutions. In environmental monitoring, biosensors are used to detect pollutants and contaminants, ensuring compliance with regulatory standards and safeguarding public health. In food safety, biosensors provide rapid detection of pathogens and toxins, ensuring the quality and safety of food products.

Breakup by End Use:

Point of Care Testing

Home Healthcare Diagnostics

Research Laboratories

Security and Biodefense

Others

The report has provided a detailed breakup and analysis of the market based on the end use. This includes point of care testing, home healthcare diagnostics, research laboratories, security and biodefense, and others.

The point-of-care testing (POCT) segment is driven by the increasing demand for rapid diagnostic results and the need for immediate clinical decision-making. This demand is fueled by the growing prevalence of chronic diseases such as diabetes and cardiovascular conditions, which require continuous monitoring and timely management. Technological advancements in biosensors have made these devices more portable, user-friendly, and capable of delivering accurate results quickly, enhancing their adoption in decentralized settings like clinics, emergency rooms, and even patients' homes. Additionally, the emphasis on reducing healthcare costs and improving patient outcomes has led to a shift towards point-of-care testing, allowing for faster diagnosis and treatment, thus minimizing hospital visits and stays.

The home healthcare diagnostics segment is driven by the increasing preference for convenient and accessible healthcare solutions. With the rise in the aging population and the growing burden of chronic diseases, there is a significant demand for home-based diagnostic tools that enable continuous monitoring and management of health conditions without frequent hospital visits. Advances in biosensor technology have facilitated the development of portable, easy-to-use devices that patients can operate independently, ensuring real-time health monitoring and early detection of potential health issues.

The research laboratories segment is driven by the increasing need for advanced diagnostic and analytical tools in scientific research and development. Biosensors play a crucial role in various research applications, including disease pathology, drug development, environmental monitoring, and biotechnology. The precision, sensitivity, and versatility of biosensors make them indispensable in detecting and quantifying biological molecules and pathogens, facilitating groundbreaking research and innovation. The continuous advancement in biosensor technology, including the integration of nanotechnology and microfluidics, enhances their performance, making them even more valuable in research settings.

The security and biodefense segment is driven by the increasing concerns over bioterrorism, infectious disease outbreaks, and the need for robust public safety measures. Biosensors are critical in this context due to their ability to provide rapid, accurate detection of biological and chemical threats, enabling timely response and mitigation. Governments and defense organizations invest heavily in biosensor technology to enhance national security and safeguard public health. The development of portable and real-time biosensors supports field deployment, making them essential tools for military and homeland security operations.

The others segment is driven by the increasing demand for biosensors in diverse applications beyond traditional healthcare and security uses. This includes industries such as agriculture, food and beverage, environmental monitoring, and industrial processes. In agriculture, biosensors are used for soil and crop health monitoring, ensuring optimal yield and quality. In the food and beverage industry, they are crucial for quality control and safety assurance by detecting contaminants and pathogens. Environmental monitoring applications benefit from biosensors' ability to detect pollutants and toxins in air, water, and soil, contributing to sustainability efforts.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The North America regional market is driven by the increasing prevalence of chronic diseases such as diabetes and cardiovascular conditions, which necessitate advanced diagnostic tools. Additionally, the region benefits from robust healthcare infrastructure, significant investments in research and development, and the presence of major biosensor manufacturers. Government initiatives to promote personalized medicine and growing adoption of wearable biosensors for health monitoring further propel market growth. The high awareness and acceptance of new technologies among consumers and healthcare providers also contribute to the expanding biosensors market in North America.

The Europe regional market is driven by the increasing focus on early disease detection and preventive healthcare, supported by substantial government funding and initiatives. The region's strong regulatory framework ensures high standards for biosensor development and application. Additionally, Europe's aging population contributes to a rising demand for advanced diagnostic solutions, while the presence of leading biosensor companies and extensive research activities foster innovation. Growing applications in environmental monitoring and food safety, along with collaboration between academic institutions and industry players, further accelerate market growth in Europe.

The Asia Pacific regional market is driven by the increasing healthcare needs due to a large and rapidly aging population, along with the rising prevalence of chronic diseases. Economic growth and improving healthcare infrastructure in countries like China and India enhance access to advanced diagnostic tools. Government initiatives to boost healthcare innovation and substantial investments in biosensor research and development also play a crucial role. Moreover, the expanding applications of biosensors in environmental monitoring and food safety, coupled with growing consumer awareness, contribute to the robust market growth in the Asia Pacific region.

The Latin America regional market is driven by the increasing demand for advanced healthcare solutions to address the rising incidence of chronic diseases. Improving healthcare infrastructure and government initiatives aimed at enhancing healthcare access and quality stimulate market growth. Additionally, growing awareness about the benefits of early disease detection and the adoption of point-of-care testing drive the demand for biosensors. The presence of local biosensor manufacturers and ongoing research and development activities further support market expansion.

The Middle East and Africa regional market is driven by the increasing need for improved healthcare services amidst a growing prevalence of chronic diseases and infectious conditions. Government efforts to enhance healthcare infrastructure and increase investments in medical technology bolster the market. Additionally, the adoption of advanced diagnostic tools and point-of-care testing is gaining traction. Rising awareness about early disease detection, coupled with international collaborations and partnerships, supports market growth.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the biosensors include Abbott Laboratories, AgaMatrix Inc. (WaveForm Technologies Inc), DuPont de Nemours Inc., F. Hoffmann-La Roche AG, General Electric Company, LifeScan Inc. (Platinum Equity LLC), Medtronic PLC, Nova Biomedical Corporation, PHC Holdings Corporation, Siemens AG, Thermo Fisher Scientific Inc., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players in the global biosensors market are actively pursuing various strategies to strengthen their market positions and drive growth. They are heavily investing in R&D to innovate and enhance the sensitivity, accuracy, and functionality of biosensors. Collaborations and partnerships with academic institutions, research organizations, and other industry stakeholders are being forged to accelerate technological advancements and expand application areas. Companies are also focusing on strategic acquisitions and mergers to broaden their product portfolios and gain access to new markets. Additionally, there is a strong emphasis on developing wearable and portable biosensors to cater to the rising demand for point-of-care testing and remote health monitoring. Marketing efforts are geared towards increasing awareness and adoption of biosensors across diverse sectors such as healthcare, environmental monitoring, and food safety. Regulatory compliance and obtaining necessary approvals are also prioritized to ensure product reliability and market acceptance.

Biosensors Market News:

In 2024: Abbott received CE Mark approval for its AVEIR(TM) DR, the world's first dual chamber leadless pacemaker system, marking a milestone in cardiac care innovation. Additionally, Abbott has been expanding its continuous glucose monitoring (CGM) technology beyond traditional diabetic applications.

In 2024: Siemens introduced its new biosensor platform, Atellica(TM) PM, designed to provide high-throughput and precise diagnostics in clinical settings. This platform integrates advanced biosensor technology with artificial intelligence to enhance diagnostic accuracy and efficiency. Additionally, Siemens has been actively involved in research collaborations to develop next-generation biosensors.

Key Questions Answered in This Report

1. What was the size of the global biosensors market in 2023?
2. What is the expected growth rate of the global biosensors market during 2024-2032?
3. What are the key factors driving the global biosensors market?
4. What has been the impact of COVID-19 on the global biosensors market?
5. What is the breakup of the global biosensors market based on the product?
6. What is the breakup of the global biosensors market based on the technology?
7. What is the breakup of the global biosensors market based on the application?
8. What is the breakup of the global biosensors market based on the end use?
9. What are the key regions in the global biosensors market?
10. Who are the key players/companies in the global biosensors market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Biosensors Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Wearable Biosensors
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Non-Wearable Biosensors
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Technology

7.1 Electrochemical Biosensors
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Optical Biosensors
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Piezoelectric Biosensors
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Thermal Biosensors
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Nanomechanical Biosensors
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Application

8.1 Blood Glucose Testing
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Cholesterol Testing
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Blood Gas Analysis
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Pregnancy Testing
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Drug Discovery
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Infectious Disease Testing
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
8.7 Others
- 8.7.1 Market Trends
- 8.7.2 Market Forecast

9 Market Breakup by End Use

9.1 Point of Care Testing
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Home Healthcare Diagnostics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Research Laboratories
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Security and Biodefense
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 AgaMatrix Inc. (WaveForm Technologies Inc)
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 DuPont de Nemours Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 F. Hoffmann-La Roche AG
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 General Electric Company
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 LifeScan Inc. (Platinum Equity LLC)
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Medtronic PLC
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Nova Biomedical Corporation
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
- 15.3.9 PHC Holdings Corporation
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
- 15.3.10 Siemens AG
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Thermo Fisher Scientific Inc.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

バイオセンサー市場レポート：製品、技術、用途、最終用途、地域別、2024～2032年

Biosensors Market Report by Product, Technology, Application, End Use, and Region 2024-2032

バイオセンサー市場分析：

バイオセンサー市場動向：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のバイオセンサー市場

第6章 市場内訳：製品別

第7章 市場内訳：技術別

第8章 市場内訳：用途別

第9章 市場内訳：最終用途別

第10章 市場内訳：地域別

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢

List of Figures

List of Tables

Biosensors Market Analysis:

Biosensors Market Trends:

Biosensors Industry Segmentation:

Breakup by Product:

Breakup by Technology:

Breakup by Application:

Breakup by End Use:

Breakup by Region:

Competitive Landscape:

Biosensors Market News:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Biosensors Market

6 Market Breakup by Product

7 Market Breakup by Technology

8 Market Breakup by Application

9 Market Breakup by End Use

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

第1章序文

第2章調査範囲と調査手法

第3章エグゼクティブサマリー

第4章イントロダクション

第5章世界のバイオセンサー市場

第6章市場内訳：製品別

第7章市場内訳：技術別

第8章市場内訳：用途別

第9章市場内訳：最終用途別

第10章市場内訳：地域別

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第14章価格分析

第15章競合情勢